Literature DB >> 26063940

Copper(II) Complexes with N,O-Donor Ligands and Ofloxacin Drug as Antibacterial, DNA Interacting, Cytotoxic and SOD Mimic Agent.

Parag S Karia1, Pankajkumar A Vekariya1, Anshul P Patidar1, Mohan N Patel1.   

Abstract

ABSTRACT: The N,O-donor bidentate ligands (L (1) -L (7) ) derived from the reaction between chalcones and pyridinium salt of 2-acetyl furan were synthesized and characterized by IR and NMR spectroscopic techniques. Their complexes [1-7] of Cu(II) were synthesized and characterized by elemental analysis, magnetic measurements, TG analyses, IR and mass spectroscopy. Synthesized complexes were carried out for their biological elucidation using different biological experiments like minimum inhibitory concentration, DNA binding and cleavage study, cytotoxicity, and antiradical activity. Efficient cleavage of pUC19 DNA was observed for all the test complexes than the reference drug. GRAPHICAL ABSTRACT: Increase in DNA chain length and hence the relative viscosity as the complexes binds to DNA via intercalative mode and involves a strong stacking interaction between an aromatic chromophore and the DNA base pair.

Entities:  

Keywords:  Absorption titration; Antibacterial agent; Antiradical activity; N,O-donor ligands; Transition metal compounds

Year:  2015        PMID: 26063940      PMCID: PMC4456505          DOI: 10.1007/s12088-015-0525-9

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  15 in total

1.  Photocleavage of Nucleic Acids.

Authors:  Bruce Armitage
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

Review 2.  The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.

Authors:  R Martínez; L Chacón-García
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex.

Authors:  Jun Tan; Bochu Wang; Liancai Zhu
Journal:  Bioorg Med Chem       Date:  2008-12-03       Impact factor: 3.641

Review 4.  Metal complex-DNA interactions: from transcription inhibition to photoactivated cleavage.

Authors:  Leigh Jk Boerner; Jeffrey M Zaleski
Journal:  Curr Opin Chem Biol       Date:  2005-04       Impact factor: 8.822

5.  Combing databases reveals potential antibiotic producers.

Authors:  Vipin Chandra Kalia; Asha Rani; Sadhana Lal; Simrita Cheema; C P Raut
Journal:  Expert Opin Drug Discov       Date:  2007-02       Impact factor: 6.098

6.  Synthesis, characterization and biological activity of some transition metals with Schiff base derived from 2-thiophene carboxaldehyde and aminobenzoic acid.

Authors:  Gehad G Mohamed; M M Omar; Ahmed M M Hindy
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2005-06-13       Impact factor: 4.098

7.  Synthesis and reactivity studies on new copper(II) complexes: DNA binding, generation of phenoxyl radical, SOD and nuclease activities.

Authors:  Kaushik Ghosh; Pramod Kumar; Nidhi Tyagi; Udai P Singh; Vaibhave Aggarwal; Maria Camilla Baratto
Journal:  Eur J Med Chem       Date:  2010-05-19       Impact factor: 6.514

8.  A trinuclear copper(II) complex of 2,4,6-tris(di-2-pyridylamine)-1,3,5-triazine shows prominent DNA cleavage activity.

Authors:  Jingwen Chen; Xiaoyong Wang; Ying Shao; Jianhui Zhu; Yangguang Zhu; Yizhi Li; Qiang Xu; Zijian Guo
Journal:  Inorg Chem       Date:  2007-03-14       Impact factor: 5.165

9.  Characterization of a triple helix-specific ligand. BePI (3-methoxy-7H-8-methyl-11- [(3'-amino)propylamino]-benzo[e]pyrido[4,3-b]indole) intercalates into both double-helical and triple-helical DNA.

Authors:  D S Pilch; M J Waring; J S Sun; M Rougée; C H Nguyen; E Bisagni; T Garestier; C Hélène
Journal:  J Mol Biol       Date:  1993-08-05       Impact factor: 5.469

10.  Copper chelates of antirheumatic and anti-inflammatory agents: their superoxide dismutase-like activity and stability.

Authors:  N A Roberts; P A Robinson
Journal:  Br J Rheumatol       Date:  1985-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.